Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson’s Disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson’s Disease ; volume:10 ; number:1 ; day:21 ; month:8 ; year:2024 ; pages:1-6 ; date:12.2024
npj Parkinson's Disease ; 10, Heft 1 (21.8.2024), 1-6, 12.2024
- Urheber
-
Pedersen, Camilla Christina
Ushakova, Anastasia
Alves, Guido
Tysnes, Ole-Bjørn
Blennow, Kaj
Zetterberg, Henrik
Maple-Grødem, Jodi
Lange, Johannes
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-024-00768-1
- URN
-
urn:nbn:de:101:1-2411072059365.680742938487
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pedersen, Camilla Christina
- Ushakova, Anastasia
- Alves, Guido
- Tysnes, Ole-Bjørn
- Blennow, Kaj
- Zetterberg, Henrik
- Maple-Grødem, Jodi
- Lange, Johannes
- SpringerLink (Online service)
Ähnliche Objekte (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Fluid biomarkers in Alzheimer’s disease – current concepts
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions